Suchergebnisse - "Acconcia, Filippo"

PubPharm (120)

1

Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer

enthalten in: Scientific reports | 2024

von Bartoloni, S. | Pescatori, S. | Bianchi, F. | +2

2

PMM2 controls ERα levels and cell proliferation in ESR1 Y537S variant expressing breast cancer cells

enthalten in: ResearchSquare.com | 2024

von Cipolletti, M. | Acconcia, F.

3

PMM2 controls ERα levels and cell proliferation in ESR1 Y537S variant expressing breast cancer cells

enthalten in: Molecular and cellular endocrinology | 2024

von Cipolletti, M. | Acconcia, F.

4

Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer

enthalten in: bioRxiv.org | 2023

von Bartoloni, S. | Pescatori, S. | Bianchi, F. | +2

5

The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells

enthalten in: Biochemical pharmacology | 2023

von Franza, M. | Albanesi, J. | Mancini, B. | +5

6

Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway

enthalten in: International journal of molecular sciences | 2023

von Montalesi, E. | Cracco, P. | Acconcia, F. | +10

7

A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma

enthalten in: Frontiers in endocrinology | 2023

von Cipolletti, M. | Leone, S. | Bartoloni, S. | +1

8

Mechanism Underlying Naringenin Hypocholesterolemic Effects : Involvement of Estrogen Receptor α Subtype

enthalten in: International journal of molecular sciences | 2022

von Pallottini, V. | Segatto, M. | Acconcia, F. | +2

9

The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cells

enthalten in: Molecular oncology | 2022

von Bartoloni, S. | Leone, S. | Pescatori, S. | +2

10

Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers

enthalten in: International journal of molecular sciences | 2022

von Acconcia, F.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]